| Autor: |
Po-Hsin Lee, Chun-Ju Chiang, Jeng-Sen Tseng, Zhe-Rong Zheng, Kun-Chieh Chen, Cheng-Hsiang Chu, Yen-Hsiang Huang, Kuo-Hsuan Hsu, Wen-Chung Lee, Tsung-Ying Yang, Tsang-Wu Liu, Jiun-Yi Hsia, Gee-Chen Chang |
| Jazyk: |
angličtina |
| Rok vydání: |
2023 |
| Předmět: |
|
| Zdroj: |
Frontiers in Oncology, Vol 13 (2023) |
| Druh dokumentu: |
article |
| ISSN: |
2234-943X |
| DOI: |
10.3389/fonc.2023.1096683 |
| Popis: |
IntroductionFor patients with T2aN0 stage IB lung adenocarcinoma, benefits of adjuvant chemotherapy remain controversial. Here, we aimed to evaluate such benefits.MethodsThis retrospective cohort study was conducted on the database of the National Taiwan Cancer Registry. We analyzed patients with T2aN0 stage IB lung adenocarcinoma (re-classified by AJCC 8th edition) diagnosed during the period from January 2011 to December 2017. They were divided into two groups: (1) group 1: tumor 3 cm, but 3 cm, but |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
